ATE363271T1 - Verfahren zur verbesserung der grösse und des aussehens einer wunde - Google Patents

Verfahren zur verbesserung der grösse und des aussehens einer wunde

Info

Publication number
ATE363271T1
ATE363271T1 AT01918824T AT01918824T ATE363271T1 AT E363271 T1 ATE363271 T1 AT E363271T1 AT 01918824 T AT01918824 T AT 01918824T AT 01918824 T AT01918824 T AT 01918824T AT E363271 T1 ATE363271 T1 AT E363271T1
Authority
AT
Austria
Prior art keywords
inhibitor
appearance
improving
size
wound
Prior art date
Application number
AT01918824T
Other languages
English (en)
Inventor
Mary Capelli-Schellpfeffer
Original Assignee
Avocet Polymer Technologies In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avocet Polymer Technologies In filed Critical Avocet Polymer Technologies In
Application granted granted Critical
Publication of ATE363271T1 publication Critical patent/ATE363271T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Lighting Device Outwards From Vehicle And Optical Signal (AREA)
AT01918824T 2000-03-17 2001-03-16 Verfahren zur verbesserung der grösse und des aussehens einer wunde ATE363271T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19019800P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
ATE363271T1 true ATE363271T1 (de) 2007-06-15

Family

ID=22700387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918824T ATE363271T1 (de) 2000-03-17 2001-03-16 Verfahren zur verbesserung der grösse und des aussehens einer wunde

Country Status (7)

Country Link
US (1) US20020013300A1 (de)
EP (1) EP1278517B1 (de)
AT (1) ATE363271T1 (de)
CA (1) CA2406024C (de)
DE (1) DE60128673D1 (de)
ES (1) ES2290120T3 (de)
WO (1) WO2001070210A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038957A1 (es) * 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP4868687B2 (ja) * 2002-09-30 2012-02-01 帝國製薬株式会社 ケロイド等の形成抑制外用剤
WO2004111192A2 (en) * 2003-05-29 2004-12-23 The Scripps Research Institute Targeted delivery to legumain-expressing cells
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050106221A1 (en) * 2003-11-14 2005-05-19 Nash Alan E. Kit for the treatment of a corn or a callus
EP1691745B1 (de) * 2003-12-11 2011-02-02 Teikoku Pharma USA, Inc. Verfahren und zusammensetzungen für die behandlung von hautwunden
EP1716854A4 (de) * 2004-02-16 2010-01-20 Teikoku Seiyaku Kk Äusserlich anzuwendende zubereitung zur behandlung schmerzhafter hautwunden
BRPI0516830A (pt) 2004-10-01 2008-09-23 Ramscor Inc composições de droga de liberação sustentada convenientemente implantáveis
EP1919444A2 (de) * 2005-04-27 2008-05-14 Avocet Polymer Technologies, Inc. Zusammensetzungen auf polyethylenglykolbasis für die topische behandlung einer geschlossenen wunde mit therapeutischen pharmazeutika
AU2006274530B2 (en) * 2005-08-01 2009-03-12 Hawk Medical Technologies Ltd. Eradication of pigmentation and scar tissue
DE102005055497A1 (de) 2005-11-18 2007-05-31 Stockhausen Gmbh Geruchsbindende superabsorbierende Zusammensetzung
US20070265346A1 (en) * 2006-04-11 2007-11-15 Anita Mehta Combination therapy for the treatment and improvement of scars
EP2054089B1 (de) 2006-08-03 2018-12-26 The Board of Trustees of the Leland Stanford Junior University Vorrichtungen und bandagen zur behandlungen bzw. prävention von narben und/oder keloiden sowie verfahren und kits dafür
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
US9358009B2 (en) 2007-08-03 2016-06-07 Neodyne Biosciences, Inc. Skin straining devices and methods
DE102007045724B4 (de) 2007-09-24 2012-01-26 Evonik Stockhausen Gmbh Superabsorbierende Zusammensetzung mit Tanninen zur Geruchskontrolle, Verfahren zu deren Herstellung und Verwendung
TWI455973B (zh) * 2008-03-05 2014-10-11 Evonik Degussa Gmbh 用於氣味控制的具有水楊酸鋅的超吸收性組合物
WO2010025430A2 (en) * 2008-08-29 2010-03-04 Nancy Josephine Polich Homeopathic therapeutic method
US20100274205A1 (en) * 2009-04-24 2010-10-28 Morelli Rocco R Wound care kit
KR101805519B1 (ko) 2009-08-11 2018-01-10 네오다인 바이오사이언시스, 인코포레이티드 어플리케이터 드레싱 장치 및 방법
EP2661246A4 (de) 2011-01-07 2015-07-29 Neodyne Biosciences Inc Vorrichtungen und verfahren zur wund- oder hautbehandlung
WO2012119131A1 (en) 2011-03-03 2012-09-07 Neodyne Biosciences, Inc. Devices and methods for skin tightening
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
US10561359B2 (en) 2011-12-02 2020-02-18 Neodyne Biosciences, Inc. Elastic devices, methods, systems and kits for selecting skin treatment devices
US10213350B2 (en) 2012-02-08 2019-02-26 Neodyne Biosciences, Inc. Radially tensioned wound or skin treatment devices and methods
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
CN107249574A (zh) * 2014-09-30 2017-10-13 重庆民济医疗器械有限公司 水凝胶组合物、其制备方法及其应用
US20220379018A1 (en) 2019-12-10 2022-12-01 Neodyne Biosciences, Inc. Tensioned infusion systems with removable hubs

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2113374A (en) * 1936-02-18 1938-04-05 Colgate Palmolive Peet Co Salicylic acid derivatives
US3119739A (en) * 1961-05-03 1964-01-28 Wanda L Campbell Acetylmethyl-salicylate for pain relief
US3419006A (en) * 1966-08-08 1968-12-31 Union Carbide Corp Novel dressing and use thereof
US3664343A (en) * 1969-10-06 1972-05-23 Union Carbide Corp Disposable articles
US3800792A (en) * 1972-04-17 1974-04-02 Johnson & Johnson Laminated collagen film dressing
US3993551A (en) * 1973-09-10 1976-11-23 Union Carbide Corporation Process for cocrosslinking water soluble polymers and products thereof
US4126681A (en) * 1975-12-08 1978-11-21 The Procter & Gamble Company Topical composition containing acetyl salicylic acid
DE2707537A1 (de) * 1976-02-23 1977-08-25 Barnes Hind Pharm Inc Praeparat zur lokalbehandlung der hypertrophischen narbenbildung bei akne
US4244948A (en) * 1979-05-07 1981-01-13 Allergan Pharmaceuticals, Inc. Medical use of esters of acetylsalicylic acid to treat acne
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
DE3224382A1 (de) * 1982-06-30 1984-01-12 Beiersdorf Ag, 2000 Hamburg Verbandmaterial auf hydrogelbasis und verfahren zu dessen herstellung
IT1169978B (it) * 1983-12-13 1987-06-03 Bella Agatina Di Preparato per la cura delle ustioni
US4659700A (en) * 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
GB2192142B (en) * 1986-07-04 1990-11-28 Johnson & Johnson Wound dressing
US4646730A (en) * 1986-05-23 1987-03-03 Johnson & Johnson Products, Inc. Color stabilized hydrogel dressing and process
US4909244B1 (en) * 1986-11-26 1994-07-05 Kendall & Co Hydrogel wound dressing
FR2618337B1 (fr) * 1987-07-22 1989-12-15 Dow Corning Sa Pansement chirurgical et procede pour le fabriquer
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
US5521087A (en) * 1989-05-10 1996-05-28 Massachusetts Institute Of Technology Method for producing oriented connective tissue cells in a ligament configuration
US5132119A (en) * 1989-07-31 1992-07-21 Massachusetts Institute Of Technology Treatment of hypertrophic wound healing disorders with calcium channel blockers
US5569678A (en) * 1989-07-31 1996-10-29 Massachusetts Institute Of Technology Control of wound scar production
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
WO1998007425A1 (en) * 1996-08-21 1998-02-26 Smithkline Beecham Corporation Imidazole compounds, compositions and use
RS50086B (sr) * 1999-04-22 2009-01-22 Biogen Idec Ma Inc., Upotreba antagonista subjedinica alfa-4 integrina za pripremanje farmaceutskog preparata za tretiranje fibroze
WO2001012130A1 (en) * 1999-08-16 2001-02-22 Dung Phan Compositions and methods of treatment for skin conditions using extracts of turmeric

Also Published As

Publication number Publication date
DE60128673D1 (de) 2007-07-12
ES2290120T3 (es) 2008-02-16
WO2001070210A3 (en) 2002-10-24
WO2001070210A2 (en) 2001-09-27
CA2406024A1 (en) 2001-09-27
EP1278517A2 (de) 2003-01-29
CA2406024C (en) 2012-05-22
US20020013300A1 (en) 2002-01-31
EP1278517B1 (de) 2007-05-30

Similar Documents

Publication Publication Date Title
ATE363271T1 (de) Verfahren zur verbesserung der grösse und des aussehens einer wunde
HK1071521A1 (en) Use of a composition comprising cis-clomiphene andtrans-clomiphene in the preparation of a medicament for increasing serum levels of testosterone
EE200200328A (et) Multši kompositsioon ja meetod
ATE276736T1 (de) Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion
PT991619E (pt) Inibidores da adesao celular mediada pela alfa4beta1
DE69525847D1 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
DK1596880T3 (da) Fremgangsmåder og sammensætninger til undertrykkelse af fibrocytdifferentiering
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
WO2007005720A3 (en) Methods and compositions for promoting wound healing
WO2001034172A3 (en) Methods and compositions for treating reward deficiency syndrome
CA2418167A1 (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
EE200300305A (et) Geelkompositsioon ja kompositsiooni transskrotaalne kasutamine hüpogonadismi raviks
TW200744660A (en) Oral composition containing morin
DE60118882D1 (de) Verwendung des dheas oder bestimmte seiner derivaten zur verbesserung des papyrus-ähnliches aussehens der haut
BR0009194A (pt) Composição do resorcinol
BR0111785A (pt) Composições e métodos para tratamento de candidìase
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
ATE274044T1 (de) Zusammensetzungen zur behandlung von gewebe
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
WO2002041832A3 (en) Compositions having comfrey and methods for reducing retinoid-induced skin irritation
DE60111921D1 (de) Dextrinhaltige zusammensetzungen zur vermeidung von adhäsionen
NO20041508L (no) Rengjoringspreparat.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties